Dolly Jacob

Title: Dolly Jacob: Innovator in Glucocorticoid Receptor Modulation

Introduction

Dolly Jacob is a prominent inventor based in Nottingham, GB. She has made significant contributions to the field of pharmacology, particularly in the development of glucocorticoid receptor modulators. Her innovative work has the potential to impact therapeutic approaches for various medical conditions.

Latest Patents

Dolly Jacob holds a patent for the formulation of dazucorilant, a glucocorticoid receptor modulator. The patent details formulations of (R)-(1-(4-fluorophenyl)-6-((4-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(pyridin-2-yl)methanone, along with methods of making and using the same. This patent represents her innovative approach to drug formulation and development.

Career Highlights

Dolly Jacob is associated with Corcept Therapeutics Incorporated, where she applies her expertise in drug development. Her work at Corcept Therapeutics has positioned her as a key player in the advancement of therapeutic solutions targeting glucocorticoid receptors.

Collaborations

Dolly collaborates with notable colleagues, including Rick Bastin and Alla Hosny. These partnerships enhance her research and development efforts, contributing to the success of her projects.

Conclusion

Dolly Jacob's contributions to the field of pharmacology through her innovative patent and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in therapeutic treatments.